Prognostic value of p53 was already reported in hepatocellular carcinoma and upper urinary tract urothelial carcinoma [154, 155], but no prognostics value in astrocytoma and Hodgkin’s lymphoma [156, 157]. This evidence concerns the gene TP53 and hepatocellular carcinoma.